Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

15.53 +0.74 (+5.00%)
Streaming Delayed Price Updated: 12:03 PM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
5 Analysts Have This to Say About Tandem Diabetes Care
Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Tandem Diabetes Care to Announce Third Quarter 2022 Financial Results on November 2, 2022
From Tandem Diabetes Care, Inc.
Via Business Wire
Short Volatility Alert: Tandem Diabetes Care, Inc.
On Monday, shares of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) experienced volatile short activity. After the activity, the stock price went up +5.42% to $50.59. The overall sentiment for TNDM has been... 
Via Benzinga
Chemours, Alcoa And Other Big Losers From Wednesday
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Where Tandem Diabetes Care Stands With Analysts
Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
Gainers 
Via Benzinga
These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022
We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022. 
Via Talk Markets
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
Via Benzinga
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 529 companies set new 52-week lows. 
Via Benzinga
Tandem Diabetes Care Achieves Milestone of 1 Million Insulin Boluses Delivered Using Its t:connect Mobile App
From Tandem Diabetes Care, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 62 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022
  
Via Benzinga
Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday
U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
NVIDIA To $240? Here Are 5 Other Price Target Changes For Tuesday
Raymond James cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to... 
Via Benzinga
Clorox, Crocs And Some Other Big Stocks Moving Lower On Thursday
  AMTD Digital Inc. (NYSE: HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days. 
Via Benzinga
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share... 
Via Benzinga
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. 
Via Benzinga
What 4 Analyst Ratings Have To Say About Tandem Diabetes Care
Analysts have provided the following ratings for Tandem Diabetes Care (NASDAQ:TNDM) within the last quarter: 
Via Benzinga
Tandem Diabetes Care: Q2 Earnings Insights
Tandem Diabetes Care (NASDAQ:TNDM) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical
From Tandem Diabetes Care, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 326 stocks hit new 52-week lows. 
Via Benzinga
Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Welcomes Two New Members to Board of Directors
From Tandem Diabetes Care, Inc.
Via Business Wire
Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes
From Tandem Diabetes Care, Inc.
Via Business Wire
Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks
The deal would have been transformative, but may have limited teamwork in the space. 
Via Investor's Business Daily
How The Rumored Dexcom-Insulet Marriage Could Rock The Entire Diabetes Space
One analyst called the rumored deal "transformative," but says the timing is unfavorable. 
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 951 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 540 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.